iBio, Inc. (IBIO) financial statements and ratios from SEC XBRL: revenue $400000.00 (TTM), net margin -4594.3%, revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $400000.00 |
| Net Margin | -4594.3% |
| Revenue Growth (YoY) | -100.0% |
| EPS Growth (YoY) | -81.3% |
| FCF Growth (YoY) | 51.0% |
| Price / Book | 0.92 |
| Price / Sales | 94.50 |
| FCF Yield | -63.5% |
| Altman Z-Score | -20.46 (distress) |
| Sector P/E (Healthcare) | 21.7 |
IBIO overview · IBIO earnings · IBIO KPIs · IBIO investor relations · IBIO ownership · IBIO peers · IBIO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.